KRAS and pancreatic adenocarcinoma: To test this hypothesis, we first subcutaneously transplanted murine pancreatic adenocarcinoma PANC02 cells into C57BL/6 mice, as PANC02 cells harbors K-RAS mutations and exhibit a similar behavior to human pancreatic cancer cells [34].